Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

This study has been terminated.
(Difficulty recruiting patients, company closed down)
Sponsor:
Collaborators:
Anders Perner
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Thrombologic ApS
ClinicalTrials.gov Identifier:
NCT01532544
First received: January 30, 2012
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)